Resistin impairs glucose permeability in EA.hy926 cells by down-regulating GLUT1 expression

[1]  Ruei-Ming Chen,et al.  Gold Nanoparticles Increase Endothelial Paracellular Permeability by Altering Components of Endothelial Tight Junctions, and Increase Blood-Brain Barrier Permeability in Mice. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  J. Klepper.  GLUT1 deficiency syndrome and ketogenic diet therapies: missing rare but treatable diseases? , 2015, Developmental medicine and child neurology.

[3]  T. Michiue,et al.  Tissue-dependent VEGF and GLUT1 induction in a rat hemorrhage model: With regard to diagnostic application of mRNA quantification in forensic pathology. , 2015, Forensic science international.

[4]  Jing Ma,et al.  A Protein Kinase C Phosphorylation Motif in GLUT1 Affects Glucose Transport and is Mutated in GLUT1 Deficiency Syndrome. , 2015, Molecular cell.

[5]  Yunhui Liu,et al.  Permeability of the blood–tumor barrier is enhanced by combining vascular endothelial growth factor with papaverine , 2014, Journal of neuroscience research.

[6]  A. Klip,et al.  Electrical Stimuli Release ATP to Increase GLUT4 Translocation and Glucose Uptake via PI3Kγ-Akt-AS160 in Skeletal Muscle Cells , 2013, Diabetes.

[7]  C. Aguilar-Salinas,et al.  Metformin decreases plasma resistin concentrations in pediatric patients with impaired glucose tolerance: a placebo-controlled randomized clinical trial. , 2012, Metabolism: clinical and experimental.

[8]  M. Roden,et al.  The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact. , 2011, Trends in pharmacological sciences.

[9]  A. del Arco,et al.  S-resistin inhibits adipocyte differentiation and increases TNFalpha expression and secretion in 3T3-L1 cells. , 2010, Biochimica et biophysica acta.

[10]  M. Ōsawa,et al.  Disruption of Endothelial Tight Junctions in a Patient with Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) , 2010, Neuropediatrics.

[11]  G. Petersen,et al.  Overweight, obesity, and pancreatic cancer: beyond risk alone. , 2009, JAMA.

[12]  M. Balda,et al.  Tight junctions at a glance , 2008, Journal of Cell Science.

[13]  K. Højlund,et al.  Adiponectin and its response to thiazolidinediones are associated with insulin‐mediated glucose metabolism in type 2 diabetic patients and their first‐degree relatives , 2008, Diabetes, obesity & metabolism.

[14]  F. Pifferi,et al.  n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[15]  F. Liu,et al.  Prolonged exposure to resistin inhibits glucose uptake in rat skeletal muscles , 2007, Acta Pharmacologica Sinica.

[16]  Gangyi Yang,et al.  High-Fat- and Lipid-Induced Insulin Resistance in Rats: The Comparison of Glucose Metabolism, Plasma Resistin and Adiponectin Levels , 2007, Annals of Nutrition and Metabolism.

[17]  E. Ravussin,et al.  Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. , 2006, Diabetes care.

[18]  L. Sechi,et al.  Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. , 2006, The Journal of clinical endocrinology and metabolism.

[19]  E. Yeh,et al.  Resistin Promotes Smooth Muscle Cell Proliferation Through Activation of Extracellular Signal–Regulated Kinase 1/2 and Phosphatidylinositol 3-Kinase Pathways , 2004, Circulation.

[20]  B. Monia,et al.  Role of resistin in diet-induced hepatic insulin resistance. , 2004, The Journal of clinical investigation.

[21]  Rudy Pandjaitan,et al.  The small GTPase Rab13 regulates assembly of functional tight junctions in epithelial cells. , 2002, Molecular biology of the cell.

[22]  P. Libby,et al.  PPAR Activators as Antiinflammatory Mediators in Human T Lymphocytes: Implications for Atherosclerosis and Transplantation-Associated Arteriosclerosis , 2002, Circulation research.

[23]  H. Sul,et al.  A Cysteine-rich Adipose Tissue-specific Secretory Factor Inhibits Adipocyte Differentiation* , 2001, The Journal of Biological Chemistry.

[24]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[25]  B. Pannier,et al.  [Hypertension and obesity]. , 2000, Archives des maladies du coeur et des vaisseaux.

[26]  W. Wahli,et al.  Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.

[27]  B. Spiegelman,et al.  PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro , 1999 .

[28]  B. Spiegelman,et al.  Adipose Expression of the Phosphoenolpyruvate Carboxykinase Promoter Requires Peroxisome Proliferator-activated Receptor γ and 9-cis-Retinoic Acid Receptor Binding to an Adipocyte-specific Enhancer in Vivo* , 1999, The Journal of Biological Chemistry.

[29]  B. Shin,et al.  Colocalization of tight junction proteins, occludin and ZO-1, and glucose transporter GLUT1 in cells of the blood-ocular barrier in the mouse eye , 1998, Histochemistry and Cell Biology.

[30]  L. Rubin.  Endothelial cells: adhesion and tight junctions , 1992, Current Biology.

[31]  K. Overvad,et al.  Abdominal obesity and fatty liver. , 2007, Epidemiologic reviews.

[32]  R. Palanivel,et al.  Regulation of insulin signalling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin , 2005, Diabetologia.

[33]  S. Mudaliar,et al.  New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers. , 2001, Annual review of medicine.

[34]  B. Spiegelman,et al.  PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. , 1999, Molecular cell.